FI950951L - Farmaseuttisia aineita veren uudelleenvirtauksesta sydämen läpi aiheutuneen sydänlihasvaurion ja sydänpysähdyksen hoitamiseksi - Google Patents

Farmaseuttisia aineita veren uudelleenvirtauksesta sydämen läpi aiheutuneen sydänlihasvaurion ja sydänpysähdyksen hoitamiseksi Download PDF

Info

Publication number
FI950951L
FI950951L FI950951A FI950951A FI950951L FI 950951 L FI950951 L FI 950951L FI 950951 A FI950951 A FI 950951A FI 950951 A FI950951 A FI 950951A FI 950951 L FI950951 L FI 950951L
Authority
FI
Finland
Prior art keywords
regurgitation
heart
blood
treatment
pharmaceutical agents
Prior art date
Application number
FI950951A
Other languages
English (en)
Swedish (sv)
Other versions
FI950951A0 (fi
FI950951A7 (fi
Inventor
Elizabeth A Kitsis
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of FI950951A0 publication Critical patent/FI950951A0/fi
Publication of FI950951L publication Critical patent/FI950951L/fi
Publication of FI950951A7 publication Critical patent/FI950951A7/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
FI950951A 1994-03-02 1995-03-01 Farmaseuttisia aineita veren uudelleenvirtauksesta sydämen läpi aiheutuneen sydänlihasvaurion ja sydänpysähdyksen hoitamiseksi FI950951A7 (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US20484494A 1994-03-02 1994-03-02

Publications (3)

Publication Number Publication Date
FI950951A0 FI950951A0 (fi) 1995-03-01
FI950951L true FI950951L (fi) 1995-09-03
FI950951A7 FI950951A7 (fi) 1995-09-03

Family

ID=22759686

Family Applications (1)

Application Number Title Priority Date Filing Date
FI950951A FI950951A7 (fi) 1994-03-02 1995-03-01 Farmaseuttisia aineita veren uudelleenvirtauksesta sydämen läpi aiheutuneen sydänlihasvaurion ja sydänpysähdyksen hoitamiseksi

Country Status (11)

Country Link
EP (1) EP0679396A1 (fi)
JP (1) JPH07267859A (fi)
KR (1) KR950026521A (fi)
CN (1) CN1112919A (fi)
AU (1) AU1355095A (fi)
CA (1) CA2143544A1 (fi)
FI (1) FI950951A7 (fi)
HU (1) HUT71896A (fi)
IL (1) IL112747A0 (fi)
RU (1) RU95102777A (fi)
ZA (1) ZA951679B (fi)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6534651B2 (en) * 2000-04-06 2003-03-18 Inotek Pharmaceuticals Corp. 7-Substituted isoindolinone inhibitors of inflammation and reperfusion injury and methods of use thereof
CN101365478B (zh) * 2005-12-21 2016-06-22 法明知识产权股份有限公司 C1抑制剂在预防缺血-再灌注损伤中的应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4556672A (en) * 1984-03-19 1985-12-03 Pfizer Inc. 3-Substituted 2-oxindole-1-carboxamides as analgesic and anti-inflammatory agents
ES2053609T3 (es) * 1987-04-24 1994-08-01 Abbott Lab Derivados de urea inhibidores de lipoxigenasa.
US5047554A (en) * 1989-04-18 1991-09-10 Pfizer Inc. 3-substituted-2-oxindole derivatives
CA2084290A1 (en) * 1990-06-12 1991-12-13 Jerry L. Adams Inhibition of 5-lipoxygenase and cyclooxygenase pathway mediated diseases
WO1992010190A1 (en) * 1990-12-13 1992-06-25 Smithkline Beecham Corporation Novel csaids
US5140047A (en) * 1991-05-03 1992-08-18 Smithkline Beecham Corporation Lipoxygenase inhibitors
FR2677477B1 (fr) * 1991-06-06 1993-08-20 Bellon Labor Sa Roger Nouveaux derives de l'oxazole leur preparation, leur utilisation et les compositions pharmaceutiques qui les contiennent.

Also Published As

Publication number Publication date
JPH07267859A (ja) 1995-10-17
KR950026521A (ko) 1995-10-16
ZA951679B (en) 1996-09-02
RU95102777A (ru) 1997-01-20
HU9500636D0 (en) 1995-04-28
FI950951A0 (fi) 1995-03-01
IL112747A0 (en) 1995-05-26
CN1112919A (zh) 1995-12-06
HUT71896A (en) 1996-02-28
CA2143544A1 (en) 1995-09-03
FI950951A7 (fi) 1995-09-03
EP0679396A1 (en) 1995-11-02
AU1355095A (en) 1995-09-07

Similar Documents

Publication Publication Date Title
BR8703038A (pt) Estimulador cardiaco para deteccao e tratamento de taquiarritmias ventriculares do coracao de um paciente
FI890582A7 (fi) Biosidisten aineiden emulgoituvat konsentraatit, niistä valmistetut vesipitoiset mikroemulsiot ja näiden mikroemulsioiden käyttö puutavaran käsittelyyn
DE3752123D1 (de) Derivate des physiologisch aktiven mittels k-252
IT9022471A0 (it) Procedimento e apparecchiatura per l'abbinamento univoco di farmaci corrispondenti a una terapia pescritta a un determinato paziente
IT1177553B (it) Composti farmacologicamente attivi per il trattamento di affezioni gastrointestinali e procedimento di preparazione
FI94028B (fi) Laite nenäsairauksien diagnoosia ja hoitoa varten
DE69315930D1 (de) Implantierbares Herz-Defibrillationsgerät
DE69520403D1 (de) Herzrhythmusmessgerät
FI910413A7 (fi) Tooppiset valmisteet ihmisen kynsien hoitamiseksi
NO882406D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive urinstoff- og karbamat-forbindelser.
DK722188A (da) Bestraalingsanordning til brug ved medicinsk behandling
FI914611A7 (fi) 2-aminopyrimidiini-4-karboksamidijohdannaiset, niiden valmistus ja terapeuttinen käyttö
ATE187642T1 (de) Verwendund von norastemizol zur behandlung der allergischen rhinitis
KR950701336A (ko) 퀴놀린 유도체 또는 그의 염, 및 이를 함유하는 심질환 치료제
DE69828753D1 (de) Automatische Feststellung des Ansprechens des Herzens wärend einer nichtinvasiven Herzstimulation
EE200200305A (et) Südame arütmiate ravis kasutatavad uued asabitsüklooktaani derivaadid
DE69924940D1 (de) Herzschrittmachersystem mit erweiterter Feststellung eines plötzlichen Herzrythmusabfalls und Behandlung mit einer darauf reagierende Herzreizung
NO981564D0 (no) Terapeutisk administrering av hemoglobin ved hjertestans
NO934160L (no) 2-amino-1,2,3,4-tetrahydronaftalen-derivater med kardiovaskulaer aktivitet, fremgangsmaate for fremstilling derav samt farmasoeytiske preparater inneholdende slike
FI950951L (fi) Farmaseuttisia aineita veren uudelleenvirtauksesta sydämen läpi aiheutuneen sydänlihasvaurion ja sydänpysähdyksen hoitamiseksi
CA2091134A1 (en) Therapeutic agent for threatened abortion
FI925544A7 (fi) Bentsoehappojohdannaisia leukotrieeniin liittyvien sairauksien hoitami seen
DE69323462D1 (de) Implantierbares Herz-Defibrillationsgerät
NO894423D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive propanolaminer.
DE3674321D1 (de) Behandlung geschmeidiger gewebe.